Clinical Endoscopy

Original Articles

Predictive factors for the necessity of peroral cholangioscopy-guided lithotripsy in the endoscopic treatment of cystic duct confluence stones: a retrospective study in Japan: Kazuaki Miyamoto, Takahisa Ogawa, Shinsuke Koshita, Yoshihide Kanno, Hiroaki Kusunose, Toshitaka Sakai, Keisuke Yonamine, Fumisato Kozakai, Haruka Okano, Yuto Matsuoka, Kento Hosokawa, Hidehito Sumiya, Kei Ito; Clin Endosc 2026;59(2):280-287. Published online January 9, 2026; DOI: https://doi.org/10.5946/ce.2025.195

Background
/Aims: The treatment of cystic duct confluence stones often requires peroral cholangioscopy (POCS)-guided lithotripsy. This study evaluated the efficacy of endoscopic treatment for cystic duct confluence stones and identified predictive factors for the need for POCS-guided lithotripsy.
Methods
This retrospective cohort study included 38 patients with cystic duct confluence stones treated endoscopically between September 2007 and December 2023. The primary outcome was the rate of complete stone removal. Secondary outcomes included the number of sessions, total procedure time, adverse events, and predictive factors for POCS-guided lithotripsy.
Results
The complete stone removal rate was 100%. POCS-guided lithotripsy was required in 50% of the cases. The mean number of sessions needed for stone removal was 2.05. The mean procedure time was 93.9 minutes. The incidence of adverse events was 13%. Multivariate analysis showed that a minor axis length of the stone relative to the distal bile duct diameter greater than 1.2 was an independent predictive factor for requiring POCS-guided lithotripsy.
Conclusions
Endoscopic treatment is highly effective for cystic duct confluence stones. However, POCS-guided lithotripsy was necessary when the minor axis of the stone relative to the distal bile duct diameter exceeded 1.2.

Citations

Citations to this article as recorded by

Cholangioscopy-guided ERCP: expanding diagnostic and therapeutic applications
Shengjie Yang, Hongyu Li
Frontiers in Medicine.2026;[Epub] CrossRef

2,316 View
119 Download
1 Web of Science
1 Crossref

Efficacy of double half-pigtail plastic stents for endoscopic biliary drainage of acute calculous cholangitis: Toshitaka Sakai, Yoshihide Kanno, Shinsuke Koshita, Takahisa Ogawa, Hiroaki Kusunose, Keisuke Yonamine, Kazuaki Miyamoto, Fumisato Kozakai, Haruka Okano, Kento Hosokawa, Hidehito Sumiya, Jun Horaguchi, Masaya Oikawa, Takashi Tsuchiya, Yutaka Noda, Kei Ito; Clin Endosc 2025;58(6):898-908. Published online November 11, 2025; DOI: https://doi.org/10.5946/ce.2025.134

Graphical Abstract Abstract PDF

Background
/Aims: Plastic stent placement is required when biliary stones cannot be completely removed during the initial endoscopic retrograde cholangiopancreatography (ERCP). Although double half-pigtail plastic stents (DHPs) help prevent stent migration, their clinical utility has not yet been evaluated.
Methods
We retrospectively reviewed data from 221 patients who underwent DHP placement for acute calculous cholangitis (ACC) between January 2015 and March 2024. Patient without complete stone removal during initial ERCP were included. Clinical success, adverse events, recurrent biliary obstruction (RBO), and time to RBO (TRBO) were compared in 21 patients treated with straight plastic stents (STs) under similar conditions.
Results
Clinical success was achieved in 99% of patients in the DHP group and 95% of the ST group (p=0.13). Adverse event rates were comparable between groups. During follow-up, the DHP group had significantly lower stent occlusion (2% vs. 20%, p<0.01) and migration rates (4% vs. 15%, p=0.02), leading to a lower RBO rate (5% vs. 35%, p<0.01). The median TRBO was significantly longer in the DHP group (585 vs. 247 days, p<0.01).
Conclusions
DHPs had comparable efficacy to STs, with significantly fewer stent-related adverse events. This may be a potential option for biliary drainage in ACC.

Citations

Citations to this article as recorded by

Clinical Outcomes of Double Half‐Pigtail Versus Straight Plastic Stents for Endoscopic Biliary Drainage of Malignant Distal Biliary Obstruction
Wataru Yoshioka, Mutsumi Tasaki, Hinata Tasaki, Hikaru Fujimoto, Shuzo Yunotani, Chika Inadomi, Shotaro Noge, Yoshihito Kubotsu, Futa Koga
DEN Open.2027;[Epub] CrossRef

3,658 View
82 Download
1 Web of Science
1 Crossref

Incidence and risk factors for recurrence of common bile duct stones in patients undergoing endoscopic extraction without prophylactic biliary stenting and subsequent cholecystectomy: a retrospective study in Japan: Hidehito Sumiya, Takahisa Ogawa, Shinsuke Koshita, Yoshihide Kanno, Hiroaki Kusunose, Toshitaka Sakai, Keisuke Yonamine, Kazuaki Miyamoto, Fumisato Kozakai, Haruka Okano, Yuto Matsuoka, Kento Hosokawa, Kei Ito; Clin Endosc 2026;59(1):124-131. Published online October 24, 2025; DOI: https://doi.org/10.5946/ce.2025.081

Graphical Abstract Abstract PDF

Background
/Aims: In patients undergoing endoscopic extraction of common bile duct stones (CBDs) and subsequent cholecystectomy, CBDs sometimes recur during the preoperative and perioperative periods. In this study, the incidence and risk factors for CBDs recurrence were investigated.
Methods
A total of 245 patients (mean age: 66 years; 138 men) who underwent cholecystectomy within 180 days of CBDs extraction between October 2017 and June 2023 were included. Recurrence was defined as the detection of the CBDs during the preoperative or perioperative period using imaging modalities such as computed tomography or re-endoscopic retrograde cholangiopancreatography, regardless of the presence of cholangitis.
Results
CBDs recurrence occurred in 4.1% of the patients (10/245). The median time to recurrence was 40 days. Preoperative recurrence was observed in nine patients, and only one patient had postoperative recurrence. Multivariate analysis identified cystic duct stones as the only significant risk factor for CBDs recurrence (hazard ratio, 15.6; 95% confidence interval, 3.7–66; p<0.001).
Conclusions
The risk of CBDs recurrence after endoscopic extraction during the pre and perioperative periods is high in patients with cystic duct stones. Prophylactic biliary stenting may be considered in high-risk patients.

Citations

Citations to this article as recorded by

Balancing surgical timing and risk stratification to prevent recurrent common bile duct stones after bile duct clearance
Sung Bum Kim
Clinical Endoscopy.2026; 59(1): 76. CrossRef
Biliary Fistula at the Margin of Liver Caused by New Common Bile Duct Stones after Hepatectomy: A Case Report and Literature Review of Bile Leakage after Liver Surgery
勇李
Asian Case Reports in Emergency Medicine.2026; 14(01): 113. CrossRef

4,522 View
192 Download
1 Web of Science
2 Crossref

Predictive factors for the diagnosis of autoimmune pancreatitis using endoscopic ultrasound-guided tissue acquisition: a retrospective study in Japan: Keisuke Yonamine, Shinsuke Koshita, Yoshihide Kanno, Takahisa Ogawa, Hiroaki Kusunose, Toshitaka Sakai, Kazuaki Miyamoto, Fumisato Kozakai, Haruka Okano, Yuto Matsuoka, Kento Hosokawa, Hidehito Sumiya, Yutaka Noda, Kei Ito; Clin Endosc 2025;58(3):457-464. Published online March 28, 2025; DOI: https://doi.org/10.5946/ce.2024.238

Graphical Abstract Abstract PDF

Background
/Aims: The factors affecting the detection rate of lymphoplasmacytic sclerosing pancreatitis (LPSP) using endoscopic ultrasound-guided tissue acquisition (EUS-TA) in patients with type 1 autoimmune pancreatitis (AIP) have not been thoroughly studied. Therefore, we conducted a retrospective study to identify the predictive factors for histologically detecting level 1 or 2 LPSP using EUS-TA.
Methods
Fifty patients with AIP were included in this study, and the primary outcome measures were the predictive factors for histologically detecting level 1 or 2 LPSP using EUS-TA.
Results
Multivariate analysis identified the use of fine needle biopsy (FNB) needles as a significant predictive factor for LPSP detection (odds ratio, 15.1; 95% confidence interval, 1.62–141; ¬¬p=0.017). The rate of good-quality specimens (specimen adequacy score ≥4) was significantly higher for the FNB needle group than for the fine needle aspiration (FNA) needle group (97% vs. 56%; p<0.01), and the FNB needle group required significantly fewer needle passes than the FNA needle group (median, 2 vs. 3; p<0.01).
Conclusions
The use of FNB needles was the most important factor for the histological confirmation of LPSP using EUS-TA in patients with type 1 AIP.

Citations

Citations to this article as recorded by

Type 1 autoimmune pancreatitis presenting with exophytic pancreatic mass formation and ascites: a case report
Yusuke Kitera, Junichi Kaneko, Shioto Suzuki, Daijiro Suzuki, Kohei Nishizawa, Yuichi Hirano, Shinya Ikeda, Takuya Otsu, Masaki Takinami, Yurimi Takahashi, Yuzo Sasada, Kazuhito Kawata, Satoshi Tamura
Gastroenterology Report.2026;[Epub] CrossRef
The diagnostic yield of endoscopic ultrasound-guided fine-needle biopsy in autoimmune pancreatitis: a systematic review and meta-analysis
Huiling Yu, Jingwei Kou, Qijin He, Dongxuan Zhang, Yalan Chen, Jie Liang
BMC Gastroenterology.2026;[Epub] CrossRef
A new era for autoimmune pancreatitis diagnosis: fine-needle biopsy outperforms fine-needle aspiration in endoscopic ultrasound-guided tissue acquisition
Gunn Huh, Tae Jun Song
Clinical Endoscopy.2025; 58(3): 406. CrossRef

4,462 View
180 Download
3 Web of Science
3 Crossref

Prophylactic endoscopic transpapillary gallbladder stenting to prevent acute cholecystitis induced after metallic stent placement for malignant biliary strictures: a retrospective study in Japan: Fumisato Kozakai, Yoshihide Kanno, Shinsuke Koshita, Takahisa Ogawa, Hiroaki Kusunose, Toshitaka Sakai, Keisuke Yonamine, Kazuaki Miyamoto, Haruka Okano, Yuto Matsuoka, Kento Hosokawa, Hidehito Sumiya, Kei Ito; Clin Endosc 2024;57(5):647-655. Published online May 17, 2024; DOI: https://doi.org/10.5946/ce.2023.284

Graphical Abstract Abstract PDF

Background
/Aims: Endoscopic biliary drainage using self-expandable metallic stents (SEMSs) for malignant biliary strictures occasionally induces acute cholecystitis (AC). This study evaluated the efficacy of prophylactic gallbladder stents (GBS) during SEMS placement.
Methods
Among 158 patients who underwent SEMS placement for malignant biliary strictures between January 2018 and March 2023, 30 patients who attempted to undergo prophylactic GBS placement before SEMS placement were included.
Results
Technical success was achieved in 21 cases (70.0%). The mean diameter of the cystic duct was more significant in the successful cases (6.5 mm vs. 3.7 mm, p<0.05). Adverse events occurred for 7 patients (23.3%: acute pancreatitis in 7; non-obstructive cholangitis in 1; perforation of the cystic duct in 1 with an overlap), all of which improved with conservative treatment. No patients developed AC when the GBS placement was successful, whereas 25 of the 128 patients (19.5%) without a prophylactic GBS developed AC during the median follow-up period of 357 days (p=0.043). In the multivariable analysis, GBS placement was a significant factor in preventing AC (hazard ratio, 0.61; 95% confidence interval, 0.37–0.99; p=0.045).
Conclusions
GBS may contribute to the prevention of AC after SEMS placement for malignant biliary strictures.

Citations

Citations to this article as recorded by

Role of Prophylactic Endoscopic Gallbladder Stent Placement for Prevention of Acute Cholecystitis in Patients Receiving Stenting for Malignant Biliary Obstruction: A Meta-Analysis
Zahid Ijaz Tarar, Mustafa Gandhi, Umer Farooq, AhtshamUllah Chaudhry, Gopala K. Konduri, Ahmad Zain, Zohaib Ahmed, Baltej Singh, Nirav Thosani
Digestive Diseases and Sciences.2026; 71(4): 1547. CrossRef
Large-diameter Plastic Stents as An Option for Preoperative Biliary Drainage for Patients with Pancreatic Cancer Undergoing Neoadjuvant Chemotherapy
Hidehito Sumiya, Yoshihide Kanno, Shinsuke Koshita, Takahisa Ogawa, Hiroaki Kusunose, Toshitaka Sakai, Keisuke Yonamine, Kazuaki Miyamoto, Fumisato Kozakai, Haruka Okano, Kento Hosokawa, Shun Nozaki, Kei Ito
The Korean Journal of Gastroenterology.2026; 86(3): 227. CrossRef
Risk Factors for Cholecystitis After Self-expandable Metallic Stent Placement for Malignant Distal Biliary Obstruction
Hashem Albunni, Azizullah Beran, Nwal Hadaki, Mark A. Gromski, Mohammad Al-Haddad
Journal of Clinical Gastroenterology.2025;[Epub] CrossRef
Risk factors for infection following particle stent placement in obstructive jaundice patients: A retrospective analysis
Gang Wang, Rui Qi
Current Problems in Surgery.2025; 67: 101775. CrossRef
Post-endoscopic retrograde cholangiopancreatography cholecystitis: A review of incidence, risk factors, prevention, and management
Suprabhat Giri, Shivaraj Afzalpurkar, Prasanna Gore, Gaurav Khatana, Saroj Kanta Sahu, Dibya Lochan Praharaj, Bipadabhanjan Mallick, Preetam Nath, Sridhar Sundaram, Manoj Kumar Sahu
World Journal of Gastrointestinal Endoscopy.2025;[Epub] CrossRef
Technical challenges and safety of prophylactic gallbladder stenting with metallic biliary stenting
Masood Muhammad Karim, Om Parkash
Clinical Endoscopy.2024; 57(6): 841. CrossRef

7,108 View
328 Download
5 Web of Science
6 Crossref

Diagnostic value of homogenous delayed enhancement in contrast-enhanced computed tomography images and endoscopic ultrasound-guided tissue acquisition for patients with focal autoimmune pancreatitis: Keisuke Yonamine, Shinsuke Koshita, Yoshihide Kanno, Takahisa Ogawa, Hiroaki Kusunose, Toshitaka Sakai, Kazuaki Miyamoto, Fumisato Kozakai, Hideyuki Anan, Haruka Okano, Masaya Oikawa, Takashi Tsuchiya, Takashi Sawai, Yutaka Noda, Kei Ito; Clin Endosc 2023;56(4):510-520. Published online April 5, 2023; DOI: https://doi.org/10.5946/ce.2022.142

Graphical Abstract Abstract PDF

Background
/Aims: We aimed to investigate (1) promising clinical findings for the recognition of focal type autoimmune pancreatitis (FAIP) and (2) the impact of endoscopic ultrasound (EUS)-guided tissue acquisition (EUS-TA) on the diagnosis of FAIP.
Methods
Twenty-three patients with FAIP were involved in this study, and 44 patients with resected pancreatic ductal adenocarcinoma (PDAC) were included in the control group.
Results
(1) Multivariate analysis revealed that homogeneous delayed enhancement on contrast-enhanced computed tomography was a significant factor indicative of FAIP compared to PDAC (90% vs. 7%, p=0.015). (2) For 13 of 17 FAIP patients (76.5%) who underwent EUS-TA, EUS-TA aided the diagnostic confirmation of AIPs, and only one patient (5.9%) was found to have AIP after surgery. On the other hand, of the six patients who did not undergo EUS-TA, three (50.0%) underwent surgery for pancreatic lesions.
Conclusions
Homogeneous delayed enhancement on contrast-enhanced computed tomography was the most useful clinical factor for discriminating FAIPs from PDACs. EUS-TA is mandatory for diagnostic confirmation of FAIP lesions and can contribute to a reduction in the rate of unnecessary surgery for patients with FAIP.

Citations

Citations to this article as recorded by

Clinical Updates in IgG4-Related Pancreatic and Hepatobiliary Disease
Hoyun Lee, Rodrigo Vieira Motta, Emma L Culver
British Journal of Hospital Medicine.2026;[Epub] CrossRef
Predictive factors for the diagnosis of autoimmune pancreatitis using endoscopic ultrasound-guided tissue acquisition: a retrospective study in Japan
Keisuke Yonamine, Shinsuke Koshita, Yoshihide Kanno, Takahisa Ogawa, Hiroaki Kusunose, Toshitaka Sakai, Kazuaki Miyamoto, Fumisato Kozakai, Haruka Okano, Yuto Matsuoka, Kento Hosokawa, Hidehito Sumiya, Yutaka Noda, Kei Ito
Clinical Endoscopy.2025; 58(3): 457. CrossRef
A new era for autoimmune pancreatitis diagnosis: fine-needle biopsy outperforms fine-needle aspiration in endoscopic ultrasound-guided tissue acquisition
Gunn Huh, Tae Jun Song
Clinical Endoscopy.2025; 58(3): 406. CrossRef
Role of endoscopic ultrasound in diagnosis and management of autoimmune pancreatitis
Gauri Kumbhar, Akhil Mahajan, Rahul Puri, Sridhar Sundaram
Indian Journal of Gastroenterology.2025; 44(6): 824. CrossRef
A multidisciplinary approach is essential for differentiating autoimmune pancreatitis from pancreatic adenocarcinoma
Sung-Hoon Moon
Clinical Endoscopy.2023; 56(4): 457. CrossRef

6,464 View
103 Download
5 Web of Science
5 Crossref

Pancreatic duct lavage cytology combined with a cell-block method for patients with possible pancreatic ductal adenocarcinomas, including pancreatic carcinoma in situ: Hiroaki Kusunose, Shinsuke Koshita, Yoshihide Kanno, Takahisa Ogawa, Toshitaka Sakai, Keisuke Yonamine, Kazuaki Miyamoto, Fumisato Kozakai, Hideyuki Anan, Kazuki Endo, Haruka Okano, Masaya Oikawa, Takashi Tsuchiya, Takashi Sawai, Yutaka Noda, Kei Ito; Clin Endosc 2023;56(3):353-366. Published online November 16, 2022; DOI: https://doi.org/10.5946/ce.2022.021

Graphical Abstract Abstract PDF

Background
/Aims: This study aimed to clarify the efficacy and safety of pancreatic duct lavage cytology combined with a cell-block method (PLC-CB) for possible pancreatic ductal adenocarcinomas (PDACs).
Methods
This study included 41 patients with suspected PDACs who underwent PLC-CB mainly because they were unfit for undergoing endoscopic ultrasonography-guided fine needle aspiration. A 6-Fr double lumen catheter was mainly used to perform PLC-CB. Final diagnoses were obtained from the findings of resected specimens or clinical outcomes during surveillance after PLC-CB.
Results
Histocytological evaluations using PLC-CB were performed in 87.8% (36/41) of the patients. For 31 of the 36 patients, final diagnoses (invasive PDAC, 12; pancreatic carcinoma in situ, 5; benignancy, 14) were made, and the remaining five patients were excluded due to lack of surveillance periods after PLC-CB. For 31 patients, the sensitivity, specificity, and accuracy of PLC-CB for detecting malignancy were 94.1%, 100%, and 96.8%, respectively. In addition, they were 87.5%, 100%, and 94.1%, respectively, in 17 patients without pancreatic masses detectable using endoscopic ultrasonography. Four patients developed postprocedural pancreatitis, which improved with conservative therapy.
Conclusions
PLC-CB has an excellent ability to detect malignancies in patients with possible PDACs, including pancreatic carcinoma in situ.

Citations

Citations to this article as recorded by

Early diagnosis of pancreatic cancer via pancreatic juice cytology with a cell-block method in a patient with altered anatomy
Yasuo Otsuka, Kosuke Minaga, Akane Hara, Kentaro Yamao, Mamoru Takenaka, Takaaki Chikugo, Masatoshi Kudo
Endoscopy International Open.2024; 12(06): E764. CrossRef
Role of endoscopic retrograde cholangiopancreatography in early diagnosis of pancreatic cancer
Yasutaka ISHII, Masahiro SERIKAWA, Shinya NAKAMURA, Juri IKEMOTO, Shiro OKA
Suizo.2024; 39(4): 247. CrossRef
Cell block created from pancreatic duct lavage is another jigsaw puzzle to diagnose early pancreatic ductal adenocarcinoma
Rungsun Rerknimitr
Clinical Endoscopy.2023; 56(3): 313. CrossRef

6,717 View
243 Download
2 Web of Science
3 Crossref

Safety and Recipient Satisfaction of Propofol Sedation in Outpatient Endoscopy: A 24-Hour Prospective Investigation Using a Questionnaire Survey: Yoshihide Kanno, Tetsuya Ohira, Yoshihiro Harada, Shinsuke Koshita, Takahisa Ogawa, Hiroaki Kusunose, Yoshiki Koike, Taku Yamagata, Toshitaka Sakai, Kaori Masu, Keisuke Yonamine, Kazuaki Miyamoto, Megumi Tanaka, Tomohiro Shimada, Fumisato Kozakai, Kazuki Endo, Haruka Okano, Daichi Komabayashi, Takeshi Shimizu, Shohei Suzuki, Kei Ito; Clin Endosc 2021;54(3):340-347. Published online December 11, 2020; DOI: https://doi.org/10.5946/ce.2020.138

Abstract PDF

Background
/Aims: The aim of this study was to evaluate the safety of sedation with propofol as an alternative to benzodiazepine drugs in outpatient endoscopy.
Methods
In this prospective study, examinees who underwent outpatient endoscopy under propofol sedation and submitted a nextday questionnaire with providing informed consent were evaluated. Periprocedural acute responses, late adverse events within 24 hours, and examinee satisfaction were evaluated.
Results
Among the 4,122 patients who received propofol in the 17,978 outpatient-based endoscopic examinations performed between November 2016 and March 2018, 2,305 eligible examinees (esophagogastroduodenoscopy for 1,340, endoscopic ultrasonography for 945, and total colonoscopy for 20) were enrolled, and their responses to a questionnaire were analyzed. The mean propofol dose was 69.6±24.4 mg (range, 20–200 mg). Diazepam, midazolam, and/or pentazocine in combination with propofol was administered to 146 examinees. Mild oxygen desaturation was observed in 59 examinees (2.6%); and mild bradycardia, in 2 (0.09%). Other severe reactions or late events did not occur. After eliminating 181 invalid responses, 97.7% (2,065/2,124) of the patients desired propofol sedation in future examinations.
Conclusions
Propofol sedation was found to be safe—without severe adverse events or accidents—for outpatient endoscopy on the basis of the patients’ next-day self-evaluation. Given the high satisfaction level, propofol sedation might be an ideal tool for painless endoscopic screening.

Citations

Citations to this article as recorded by

Comparison of sedation with pentazocine or pethidine hydrochloride for endoscopic ultrasonography in outpatients: A single‐center retrospective study
Makiko Urabe, Kenji Ikezawa, Yusuke Seiki, Ko Watsuji, Yasuharu Kawamoto, Takeru Hirao, Yugo Kai, Ryoji Takada, Takuo Yamai, Kaori Mukai, Tasuku Nakabori, Hiroyuki Uehara, Kazuyoshi Ohkawa
DEN Open.2025;[Epub] CrossRef
Risk factors for adverse reactions to nurse-administered propofol during outpatient endoscopy: a cross-sectional study
Renzo Inca Villanueva, Cynthia Bazán Montero, María Estela Bulnes-Montánchez, Lary Salazar Alva, José Salvador Carrillo, Alejandra Zevallos, Fernando Salazar
BMC Anesthesiology.2025;[Epub] CrossRef
Remimazolam, a novel drug, for safe and effective endoscopic sedation
Jae Min Lee, Yehyun Park, Dong Won Ahn, Jun Kyu Lee, Kwang Hyuck Lee
Clinical Endoscopy.2025; 58(3): 370. CrossRef
Balancing safety and effectiveness in colonoscopy for older adults: a narrative review
Min-Jae Kim, Yuna Kim, Jie-Hyun Kim, Young Hoon Youn, Jaeyoung Chun
Intestinal Research.2025; 23(4): 443. CrossRef
Remimazolam and Its Place in the Current Landscape of Procedural Sedation and General Anesthesia
Matthew Brohan, Janette Brohan, Basavana Goudra
Journal of Clinical Medicine.2024; 13(15): 4362. CrossRef
How to implement adverse events as a quality indicator in gastrointestinal endoscopy
Tom G. Moreels
Digestive Endoscopy.2024; 36(1): 89. CrossRef
Propofol Alone versus Propofol in Combination with Midazolam for Sedative Endoscopy in Patients with Paradoxical Reactions to Midazolam
Ji Hyung Nam, Dong Kee Jang, Jun Kyu Lee, Hyoun Woo Kang, Byung-Wook Kim, Byung Ik Jang
Clinical Endoscopy.2022; 55(2): 234. CrossRef
Drugs used for sedation in gastrointestinal endoscopy
Jun Kyu Lee
Journal of the Korean Medical Association.2022; 65(11): 735. CrossRef

8,857 View
176 Download
9 Web of Science
8 Crossref

Inside Plastic Stents versus Metal Stents for Treating Unresectable Malignant Perihilar Biliary Obstructions: A Retrospective Comparative Study: Yoshihide Kanno, Shinsuke Koshita, Takahisa Ogawa, Hiroaki Kusunose, Kaori Masu, Toshitaka Sakai, Keisuke Yonamine, Kazuaki Miyamoto, Toji Murabayashi, Fumisato Kozakai, Jun Horaguchi, Yutaka Noda, Kei Ito; Clin Endosc 2020;53(6):735-742. Published online March 4, 2020; DOI: https://doi.org/10.5946/ce.2020.003

Abstract PDF

Background
/Aims: The aim of this study was to evaluate outcomes of inside plastic stents (iPSs) versus those of metal stents (MSs) for treating unresectable perihilar malignant obstructions.
Methods
For all patients who underwent endoscopic suprapapillary placement of iPS(s) or MS(s) as the first permanent biliary drainage for unresectable malignant perihilar obstructions between January 2014 and August 2019, clinical outcomes using iPSs (n=20) and MSs (n=85), including clinical efficacy, adverse events, and time to recurrence of biliary obstruction (RBO), were retrospectively evaluated.
Results
There were no differences in clinical effectiveness (95% for the iPS group vs. 92% for the MS group, p=1.00). Procedure-related adverse events, including pancreatitis, acute cholangitis, acute cholecystitis, and death, were observed for 8% of the MS group, although no patient in the iPS group developed such adverse events. The median time to RBO was 561 days (95% confidence interval, 0–1,186 days) for iPSs and 209 days (127–291 days) for MSs, showing a significant difference (p=0.008).
Conclusions
Time to RBO after iPS placement was significantly longer than that after MS placement. IPSs, which are removable, unlike MSs, were an acceptable option.

Citations

Citations to this article as recorded by

Efficacy of Drainage Combining Endoscopic Retrograde Cholangiopancreatography With Endoscopic Ultrasound‐guided Biliary Drainage for Difficult‐to‐Control Cholangitis in Patients With Hilar Cholangiocarcinoma
Tomoki Ogata, Yusuke Kurita, Takamitsu Sato, Shin Yagi, Yu Honda, Takeshi Iizuka, Sho Hasegawa, Kunihiro Hosono, Noritoshi Kobayashi, Itaru Endo, Kensuke Kubota, Masato Yoneda, Atsushi Nakajima
DEN Open.2026;[Epub] CrossRef
Clinical utility of suprapapillary plastic stents for lifelong biliary drainage in unresectable malignant hilar biliary obstruction
Hisahiro Uemura, Takashi Kobayashi, Atsuhiro Masuda, Kenta Yamamoto, Kaoruko Kanamaru, Takafumi Tokunaga, Akira Shirohata, Tetsuhisa Ko, Yusuke Yokotani, Yuki Oka, Yosuke Irie, Noriko Juri, Yoshiyuki Harada, Mika Miki, Noriko Inomata, Kae Nagao, Shinya Ko
Gastrointestinal Endoscopy.2026; 103(3): 475. CrossRef
The selection and strategy of stents in endoscopic drainage of unresectable perihilar cholangiocarcinoma: a meta-analysis
Xiaoyi Guo, Jinqi Xing, Haifeng Luo, Di Zhang, Feng Gao, Zihao Dai, Jianfeng Huo, Zhuo Yang, Jiangning Gu
BMC Surgery.2026;[Epub] CrossRef
Modern endoscopic strategies for the diagnosis and management of cholangiocarcinoma
Coskun Ozer Demirtas, Anna Pelach Pueyo, Amanda H Lim, Faisal Shaukat Ali, Tyler M Berzin
Frontline Gastroenterology.2026; : flgastro-2026-103852. CrossRef
Unilateral drainage and chemotherapy prolong the patency of a plastic stent placed above the sphincter of Oddi in patients with malignant hilar biliary obstruction
Fumimasa Tomooka, Koh Kitagawa, Akira Mitoro, Yukihisa Fujinaga, Norihisa Nishimura, Tadashi Namisaki, Takemi Akahane, Kosuke Kaji, Shohei Asada, Shinya Sato, Jun‐Ichi Hanatani, Hitoshi Mori, Yuki Motokawa, Tomihiro Iwata, Hiroki Kachi, Yui Osaki, Hitoshi
DEN Open.2025;[Epub] CrossRef
Evaluating safety and efficacy of plastic versus metal stenting in malignant hilar biliary obstruction: a systematic review and meta-analysis of randomized controlled trials
Xinjie Luo, Zhicheng Huang, Kamran Ali, Khizar Hayat
Postgraduate Medical Journal.2025; 101(1195): 447. CrossRef
Development and application of an early warning model for predicting early mortality following stent placement in malignant biliary obstruction: A comparative analysis of logistic regression and artificial neural network approaches
Yongxin Ma, Jiaojiao Qi, Xusheng Zhang, Kejun Liu, Yimin Liu, Xuehai Yu, Yang Bu, Bendong Chen
Oncology Letters.2025; 29(5): 1. CrossRef
Endoscopic nasobiliary drainage versus endoscopic biliary stenting for preoperative biliary drainage in patients with malignant hilar biliary obstruction: Propensity score‐matched multicenter comparative study
Hirotoshi Ishiwatari, Takanori Kawabata, Hiroki Kawashima, Yousuke Nakai, Shin Miura, Hironari Kato, Hideyuki Shiomi, Nao Fujimori, Takeshi Ogura, Osamu Inatomi, Kensuke Kubota, Toshio Fujisawa, Mamoru Takenaka, Hiroshi Mori, Kensaku Noguchi, Yuki Fujii,
Digestive Endoscopy.2024; 36(6): 726. CrossRef
Comparison of unilateral and bilateral intraductal plastic stent placement for unresectable malignant hilar biliary obstruction: A propensity score‐matched cohort analysis
Mitsuru Okuno, Keisuke Iwata, Tsuyoshi Mukai, Yuhei Iwasa, Shinya Uemura, Kensaku Yoshida, Akinori Maruta, Takuji Iwashita, Ichiro Yasuda, Masahito Shimizu
Journal of Hepato-Biliary-Pancreatic Sciences.2024; 31(4): 284. CrossRef
A Novel Method of Calculating the Drained Liver Volume Using a 3D Volume Analyzer for Biliary Drainage of Unresectable Malignant Hilar Biliary Obstruction
Naoto Imagawa, Mitsuharu Fukasawa, Shinichi Takano, Satoshi Kawakami, Yoshimitsu Fukasawa, Hiroyuki Hasegawa, Natsuhiko Kuratomi, Shota Harai, Naruki Shimamura, Dai Yoshimura, Shoji Kobayashi, Takashi Yoshida, Mitsuaki Sato, Yuichiro Suzuki, Nobuyuki Enom
Digestive Diseases and Sciences.2024; 69(3): 969. CrossRef
Partial Stent-in-Stent Method with an Uncovered Self-Expandable Metallic Stent for Unresectable Malignant Hilar Bile Duct Obstruction
Takuya Shimosaka, Yohei Takeda, Taro Yamashita, Yuta Seki, Shiho Kawahara, Takayuki Hirai, Noriyuki Suto, Yuri Sakamoto, Wataru Hamamoto, Hiroki Koda, Takumi Onoyama, Kazuya Matsumoto, Kazuo Yashima, Hajime Isomoto, Naoyuki Yamaguchi
Journal of Clinical Medicine.2024; 13(3): 820. CrossRef
Current status of preoperative endoscopic biliary drainage for distal and hilar biliary obstruction
Hirotoshi Ishiwatari, Junya Sato, Hiroki Sakamoto, Takuya Doi, Hiroyuki Ono
Digestive Endoscopy.2024; 36(9): 969. CrossRef
Biliary drainage in hilar and perihilar cholangiocarcinoma: 25-year experience at a tertiary cancer center
Ahmad Al Nakshabandi, Faisal S. Ali, Iyad Albustami, Hyunsoo Hwang, Wei Qiao, Nicole C. Johnston, Abdullah S. Shaikh, Emmanuel Coronel, Phillip S. Ge, William Ross, Brian Weston, Jeffrey H. Lee
Gastrointestinal Endoscopy.2024; 99(6): 938. CrossRef
Safety and efficacy of biliary suprapapillary metal and plastic stents in malignant biliary obstruction: a systematic review and meta-analysis
Saqr Alsakarneh, Mahmoud Y. Madi, Fouad Jaber, Kamal Hassan, Yassine Kilani, Omar Al Ta’ani, Dushyant Singh Dahiya, Amir H. Sohail, Laith Numan, Mohammad Bilal, Wissam Kiwan
Surgical Endoscopy.2024; 38(8): 4186. CrossRef
Clinical Outcomes of Inside Stents and Conventional Plastic Stents as Bridge-to-Surgery Options for Malignant Hilar Biliary Obstruction
Hirotoshi Ishiwatari, Takanori Kawabata, Hiroki Kawashima, Yousuke Nakai, Shin Miura, Hironari Kato, Hideyuki Shiomi, Nao Fujimori, Takeshi Ogura, Osamu Inatomi, Kensuke Kubota, Toshio Fujisawa, Mamoru Takenaka, Hiroshi Mori, Kensaku Noguchi, Yuki Fujii,
Digestive Diseases and Sciences.2023; 68(4): 1139. CrossRef
Development of novel biliary metal stent with coil-spring structure and its application in vivo swine biliary stricture model
In Rae Cho, Sang Hyub Lee, Jin Ho Choi, Namyoung Park, Min Woo Lee, Joo Seong Kim, Seok Jeong, Don Haeng Lee, Tae-Won Jeong, Byoung-Yun Ki, Woo Hyun Paik, Ji Kon Ryu, Yong-Tae Kim
Frontiers in Oncology.2023;[Epub] CrossRef
Endoscopic retrograde stent drainage therapies for malignant biliary obstruction: the distal opening of stent location above or across the duodenal papilla? A systematic review and meta-analysis
Dong Fang, Yi Han, Chenglin Zhu, Zhenwang Shi, Deming Bao, Liming Wang, Qin Xu
Scandinavian Journal of Gastroenterology.2023; 58(9): 1071. CrossRef
Suprapapillary placement of plastic versus metal stents for malignant biliary hilar obstructions: a multicenter, randomized trial
Yoshihide Kanno, Kei Ito, Kazunari Nakahara, Shinya Kawaguchi, Yoshiharu Masaki, Toru Okuzono, Hironari Kato, Masaki Kuwatani, Shotaro Ishii, Toji Murabayashi, Sho Hasegawa, Masatsugu Nagahama, Yuji Iwashita, Yosuke Michikawa, Shuzo Terada, Yujiro Kawakam
Gastrointestinal Endoscopy.2023; 98(2): 211. CrossRef
Déjà vu but with a different conclusion
Richard Kozarek
Gastrointestinal Endoscopy.2023; 98(5): 787. CrossRef
Utility of bilateral intraductal plastic stent for malignant hilar biliary obstruction compared with bilateral self-expandable metal stent: a propensity score–matched cohort analysis
Mitsuru Okuno, Keisuke Iwata, Takuji Iwashita, Tsuyoshi Mukai, Kota Shimojo, Yosuke Ohashi, Yuhei Iwasa, Akihiko Senju, Shota Iwata, Ryuichi Tezuka, Hironao Ichikawa, Naoki Mita, Shinya Uemura, Kensaku Yoshida, Akinori Maruta, Eiichi Tomita, Ichiro Yasuda
Gastrointestinal Endoscopy.2023; 98(5): 776. CrossRef
Cross‐wired metal stents for endoscopic bilateral stent‐in‐stent deployment in malignant hilar biliary obstruction: A multicenter, single‐arm, prospective study
Kentaro Yamao, Takeshi Ogura, Hideyuki Shiomi, Takaaki Eguchi, Hisakazu Matsumoto, Zhao Liang Li, Hiroaki Hashimoto, Yasutaka Chiba, Mamoru Takenaka, Tomohiro Watanabe, Masatoshi Kudo, Tsuyoshi Sanuki
DEN Open.2022;[Epub] CrossRef
Recent advances regarding endoscopic biliary drainage for unresectable malignant hilar biliary obstruction
Hironari Kato, Kazuyuki Matsumoto, Hiroyuki Okada
DEN Open.2022;[Epub] CrossRef
Double‐scope method is helpful to rescue a retrieval thread attached to a stent caught on the duodenoscope forceps elevator
Kengo Matsumoto, Dai Nakamatsu, Tsutomu Nishida
Digestive Endoscopy.2022;[Epub] CrossRef
The feasibility of percutaneous transhepatic gallbladder aspiration for acute cholecystitis after self-expandable metallic stent placement for malignant biliary obstruction: a 10-year retrospective analysis in a single center
Akihisa Ohno, Nao Fujimori, Toyoma Kaku, Masayuki Hijioka, Ken Kawabe, Naohiko Harada, Makoto Nakamuta, Takamasa Oono, Yoshihiro Ogawa
Clinical Endoscopy.2022; 55(6): 784. CrossRef
Self‐expandable metal stents have longer patency and less cholangitis than inside stents in malignant perihilar biliary obstruction
Akinobu Koiwai, Morihisa Hirota, Tomofumi Katayama, Ryo Kin, Keita Kawamura, Katsuya Endo, Takayuki Kogure, Atsuko Takasu, Takayoshi Meguro, Kennichi Satoh
JGH Open.2022; 6(5): 317. CrossRef
Two-devices-in-one-channel method for preventing the preceding stent migration in case of multiple indwelling biliary inside plastic stents
Tesshin Ban, Yoshimasa Kubota, Takuya Takahama, Shun Sasoh, Tomoaki Ando, Makoto Nakamura, Takashi Joh
Endoscopy.2022; 54(S 02): E948. CrossRef
Editors' Choice of Noteworthy Clinical Endoscopy Publications in the First Decade
Gwang Ha Kim, Kwang An Kwon, Do Hyun Park, Jimin Han
Clinical Endoscopy.2021; 54(5): 633. CrossRef
Endoscopic or percutaneous biliary drainage in hilar cholangiocarcinoma: When and how?
Tudor Mocan, Adelina Horhat, Emil Mois, Florin Graur, Cristian Tefas, Rares Craciun, Iuliana Nenu, Mihaela Spârchez, Zeno Sparchez
World Journal of Gastrointestinal Oncology.2021; 13(12): 2050. CrossRef
Changing Trends in Biliary Stenting for Unresectable Malignant Perihilar Obstructions
Lubna Kamani, Muhammad Arshad
Clinical Endoscopy.2020; 53(6): 636. CrossRef

10,102 View
306 Download
28 Web of Science
29 Crossref

Predictive Value of Localized Stenosis of the Main Pancreatic Duct for Early Detection of Pancreatic Cancer: Yoshihide Kanno, Shinsuke Koshita, Takahisa Ogawa, Hiroaki Kusunose, Kaori Masu, Toshitaka Sakai, Keisuke Yonamine, Yujiro Kawakami, Yuki Fujii, Kazuaki Miyamoto, Toji Murabayashi, Fumisato Kozakai, Jun Horaguchi, Yutaka Noda, Masaya Oikawa, Takaho Okada, Kei Ito; Clin Endosc 2019;52(6):588-597. Published online November 20, 2019; DOI: https://doi.org/10.5946/ce.2019.018

Abstract PDF

Background
/Aims: In this study, we aimed to evaluate the predictive value of localized stenosis of the main pancreatic duct (MPD) for early detection of pancreatic cancer.
Methods
Among 689 patients who underwent endoscopic retrograde pancreatography from January 2008 to September 2018, 19 patients with MPD findings were enrolled. These patients showed findings for indicating suspicious pancreatic cancer at an early stage (FiCE); FiCE was defined as a single, localized stenosis in the MPD without a detectable mass (using any other imaging methods) and without other pancreatic diseases, such as definite chronic pancreatitis, intraductal papillary mucinous neoplasm, and autoimmune pancreatitis. Final diagnoses were established by examining resected specimens or through follow-up examinations after an interval of >5 years.
Results
Among 19 patients with FiCE, 11 underwent surgical resection and 8 were evaluated after a >5-year observation period. The final diagnosis of the MPD stenosis was judged to be pancreatic cancer in 9 patients (47%), including 3 with intraepithelial cancer, and to be a non-neoplastic change in 10. The sensitivity, specificity, and accuracy of preoperative pancreatic juice cytology were 75%, 100%, and 88%, respectively.
Conclusions
The predictive value of FiCE for pancreatic cancer prevalence was 47%. Histological confirmation with pancreatic juice cytology is necessary before surgical resection.

Citations

Citations to this article as recorded by

Clinical and imaging differences between pancreatic carcinoma in situ and T1a/T1b pancreatic ductal adenocarcinoma
Tatsunori Satoh, Shinya Kawaguchi, Eiji Nakatani, Haruna Takahashi, Shinya Endo, Naofumi Shirane, Hideyuki Kanemoto, Kazuya Ohno
Abdominal Radiology.2026; 51(9): 4456. CrossRef
Super-resolution deep learning–enhanced 2D MRCP improves main pancreatic duct visualization compared with 3D MRCP
Kumi Ozaki, Shoya Haseyama, Eri Sugioka, Yukichi Tanahashi, Satoshi Goshima
European Journal of Radiology.2026; 203: 113022. CrossRef
Semiannual surveillance facilitates detection of surgically treatable intraductal papillary mucinous neoplasm–derived and concomitant carcinoma: a multicenter prospective observational study
Yosuke Ohashi, Akinori Maruta, Takuya Koizumi, Shota Iwata, Shinya Uemura, Ryuichi Tezuka, Yuhei Iwasa, Mitsuru Okuno, Keisuke Iwata, Tsuyoshi Mukai, Hironao Ichikawa, Naoki Mita, Kensaku Yoshida, Takuji Iwashita, Masahito Shimizu
Pancreatology.2026; 26(5): 738. CrossRef
Clinicopathologic Outcomes After Resection of Suspected High-Grade Pancreatic Intraepithelial Neoplasia Without Invasive Carcinoma: A Multicenter Retrospective Study
Takuya Mizumoto, Yoshihide Nanno, Jun Ishida, Katsuya Ami, Kei Yamane, Yuichiro Uchida, Takeshi Takahara, Kazuyuki Nagai, Ippei Matsumoto, Takumi Fukumoto
Annals of Surgical Oncology.2026;[Epub] CrossRef
Repeated pancreatic juice cytology via endoscopic nasopancreatic drainage catheter combined with clinical findings improves diagnostic ability for malignant cases of suspected pancreatic cancer with non-identifiable tumors
Tatsunori Satoh, Junichi Kaneko, Eiji Nakatani, Hirotoshi Ishiwatari, Junya Sato, Akihiko Ohata, Reiko Yamada, Tetsuro Miwata, Kazuma Ishikawa, Fumitaka Niiya, Yosuke Kobayashi, Yasushi Hamaya, Jun Ito, Kazuhito Kawata, Azumi Suzuki, Yasunari Sakamoto, Yu
Pancreatology.2025; 25(1): 125. CrossRef
Perilesional branch duct dilation as a hallmark MRCP feature for differentiating high-grade PanIN from low-grade PanIN
Kentaro Yamao, Yasuo Takehara, Hiroshi Ogawa, Jun Nakahodo, Ryuki Minami, Ryota Sagami, Hidefumi Nishikiori, Muneyori Okita, Hidekazu Takahashi, Yoshihisa Takada, Kota Uetsuki, Tadashi Iida, Yasuyuki Mizutani, Takuya Ishikawa, Hiroki Kawashima
Pancreatology.2025; 25(5): 676. CrossRef
T1 pancreatic body cancer in which serial pancreatic juice aspiration cytological examination is useful for the diagnosis
Ryousuke Tenma, Kenichiro Imai, Takaki Furuyama, Satoru Iida, Yutaka Toukairin, Go Shibuya, Akira Fukuda, Noriyuki Kuniyoshi, Shikohumi Tei
Progress of Digestive Endoscopy.2025; 106(1): 132. CrossRef
Minor papilla approach improves technical success of nasopancreatic drainage-based pancreatic juice cytology for early pancreatic cancer diagnosis
Tatsunori Satoh, Shinya Kawaguchi, Haruna Takahashi, Yuichi Masui, Masanori Matsuda, Asami Kawai, Shinya Endo, Takafumi Kurokami, Naofumi Shirane, Kazuya Ohno
Endoscopy International Open.2025;[Epub] CrossRef
Efficient Assessment of Tumor Vascular Shutdown by Photodynamic Therapy on Orthotopic Pancreatic Cancer Using High-Speed Wide-Field Waterproof Galvanometer Scanner Photoacoustic Microscopy
Jaeyul Lee, Sangyeob Han, Til Bahadur Thapa Magar, Pallavi Gurung, Junsoo Lee, Daewoon Seong, Sungjo Park, Yong-Wan Kim, Mansik Jeon, Jeehyun Kim
International Journal of Molecular Sciences.2024; 25(6): 3457. CrossRef
Role of endoscopic retrograde cholangiopancreatography in early diagnosis of pancreatic cancer
Yasutaka ISHII, Masahiro SERIKAWA, Shinya NAKAMURA, Juri IKEMOTO, Shiro OKA
Suizo.2024; 39(4): 247. CrossRef
Difference of Risk of Pancreatic Cancer in New-Onset Diabetes and Long-standing Diabetes: A Population-based Cohort Study
Hee Seung Lee, Wonjeong Chae, Min Je Sung, Jiyoung Keum, Jung Hyun Jo, Moon Jae Chung, Jeong Youp Park, Seung Woo Park, Si Young Song, Eun-Cheol Park, Chung Mo Nam, Sung-In Jang, Seungmin Bang
The Journal of Clinical Endocrinology & Metabolism.2023; 108(6): 1338. CrossRef
Pancreatic duct lavage cytology combined with a cell-block method for patients with possible pancreatic ductal adenocarcinomas, including pancreatic carcinoma in situ
Hiroaki Kusunose, Shinsuke Koshita, Yoshihide Kanno, Takahisa Ogawa, Toshitaka Sakai, Keisuke Yonamine, Kazuaki Miyamoto, Fumisato Kozakai, Hideyuki Anan, Kazuki Endo, Haruka Okano, Masaya Oikawa, Takashi Tsuchiya, Takashi Sawai, Yutaka Noda, Kei Ito
Clinical Endoscopy.2023; 56(3): 353. CrossRef
Main pancreatic duct stenosis without detecting tumor
Katsuhiko SATO, Minoru SHIGEKAWA, Teppei YOSHIOKA, Shuhei YAMAMOTO, Takayuki MATSUMAE, Kazuhiro KOZUMI, Yu SATO, Jyunya OKABE, Takahiro KODAMA, Hayato HIKITA, Tomohide TATSUMI, Tetsuo TAKEHARA
Suizo.2023; 38(2): 147. CrossRef
Diagnostic Ability and Safety of Repeated Pancreatic Juice Cytology Using an Endoscopic Nasopancreatic Drainage Catheter for Pancreatic Ductal Adenocarcinoma: A Multicenter Prospective Study
Shinya Nakamura, Yasutaka Ishii, Masahiro Serikawa, Keiji Hanada, Noriaki Eguchi, Tamito Sasaki, Yoshifumi Fujimoto, Atsushi Yamaguchi, Shinichiro Sugiyama, Bunjiro Noma, Michihiro Kamigaki, Tomoyuki Minami, Akihito Okazaki, Masanobu Yukutake, Teruo Mouri
Diagnostics.2023; 13(16): 2696. CrossRef
Endoscopic approach in the diagnosis of high‐grade pancreatic intraepithelial neoplasia
Keiji Hanada, Akihiro Shimizu, Keisuke Kurihara, Morito Ikeda, Takuya Yamamoto, Yasuhiro Okuda, Susumu Tazuma
Digestive Endoscopy.2022; 34(5): 927. CrossRef
Current Screening Strategies for Pancreatic Cancer
Petr Vanek, Ondrej Urban, Vincent Zoundjiekpon, Premysl Falt
Biomedicines.2022; 10(9): 2056. CrossRef
Pre-Operative Imaging and Pathological Diagnosis of Localized High-Grade Pancreatic Intra-Epithelial Neoplasia without Invasive Carcinoma
Ryota Sagami, Kentaro Yamao, Jun Nakahodo, Ryuki Minami, Masakatsu Tsurusaki, Kazunari Murakami, Yuji Amano
Cancers.2021; 13(5): 945. CrossRef
New-Onset or Exacerbation of Diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic Cancer
Tetsuya Takikawa, Kazuhiro Kikuta, Kiyoshi Kume, Shin Hamada, Shin Miura, Naoki Yoshida, Seiji Hongo, Yu Tanaka, Ryotaro Matsumoto, Takanori Sano, Mio Ikeda, Masahiro Iseki, Michiaki Unno, Atsushi Masamune
The Tohoku Journal of Experimental Medicine.2020; 252(4): 353. CrossRef
Can Localized Stenosis of the Main Pancreatic Duct be a Predictive Factor for Early Detection of Pancreatic Cancer?
Mamoru Takenaka, Kentaro Yamao, Masatoshi Kudo
Clinical Endoscopy.2019; 52(6): 523. CrossRef

9,117 View
135 Download
18 Web of Science
19 Crossref

Endoscopic Ultrasonography-Guided Gallbladder Drainage as a Treatment Option for Acute Cholecystitis after Metal Stent Placement in Malignant Biliary Strictures: Fumisato Kozakai, Yoshihide Kanno, Kei Ito, Shinsuke Koshita, Takahisa Ogawa, Hiroaki Kusunose, Kaori Masu, Toshitaka Sakai, Toji Murabayashi, Keisuke Yonamine, Yujiro Kawakami, Yuki Fujii, Kazuaki Miyamoto, Yutaka Noda; Clin Endosc 2019;52(3):262-268. Published online March 15, 2019; DOI: https://doi.org/10.5946/ce.2018.183

Abstract PDF

Background
/Aims: It is often difficult to manage acute cholecystitis after metal stent (MS) placement in unresectable malignant biliary strictures. The aim of this study was to evaluate the feasibility of endoscopic ultrasonography-guided gallbladder drainage (EUS-GBD) for acute cholecystitis.
Methods
The clinical outcomes of 10 patients who underwent EUS-GBD for acute cholecystitis after MS placement between January 2011 and August 2018 were retrospectively evaluated. The procedural outcomes of percutaneous transhepatic gallbladder drainage (PTGBD) with tube placement (n=11 cases) and aspiration (PTGBA) (n=27 cases) during the study period were evaluated as a reference.
Results
The technical success and clinical effectiveness rates of EUS-GBD were 90% (9/10) and 89% (8/9), respectively. Severe bile leakage that required surgical treatment occurred in one case. Acute cholecystitis recurred after stent dislocation in 38% (3/8) of the cases. Both PTGBD and PTGBA were technically successful in all cases without severe adverse events and clinically effective in 91% and 63% of the cases, respectively.
Conclusions
EUS-GBD after MS placement was a feasible option for treating acute cholecystitis. However, it was a rescue technique following the established percutaneous intervention in the current setting because of the immature technical methodology, including dedicated devices, which need further development.

Citations

Citations to this article as recorded by

Endoscopic ultrasound-guided gallbladder drainage for acute cholecystitis: Should the endoscopic option become the status quo?
Robert Sean O'Neill, Timothy Walter, Christina Lee, Kevin Jia, Ian Turner, George Ermerak, Paul Edwards, David Abi-Hanna, Milan Bassan, Cynthuja Thilakanathan
World Journal of Gastrointestinal Pharmacology and Therapeutics.2026;[Epub] CrossRef
Endoscopic Ultrasound‐Guided Gallbladder Drainage Using a 19‐Gauge Needle and a Modified Slim Metal Stent: A Simplified Approach (With Video)
Alan Chuncharunee, Kazuo Hara, Shin Haba, Takamichi Kuwahara, Nozomi Okuno, Shimpei Matsumoto, Hiroki Koda, Keigo Oshiro, Yuma Yamazaki
Digestive Endoscopy.2026;[Epub] CrossRef
Endoscopic Ultrasound-Guided Gallbladder Drainage Using Double-Pigtail Plastic Stents for Acute Cholecystitis in Patients with Malignant Biliary Obstruction
Keiki Nagai, Yusuke Kurita, Yuji Fujita, Kensuke Kubota, Tomoki Ogata, Etsuko Yamabe, Hiroki Uechi, Yuji Koyama, Shintaro Tsujikawa, Yu Honda, Takayuki Oda, Takeshi Iizuka, Shin Yagi, Eisuke Suzuki, Seitaro Tsujino, Ken Ishii, Sho Hasegawa, Shingo Kato, M
Journal of Clinical Medicine.2026; 15(16): 6329. CrossRef
Post-endoscopic retrograde cholangiopancreatography cholecystitis: A review of incidence, risk factors, prevention, and management
Suprabhat Giri, Shivaraj Afzalpurkar, Prasanna Gore, Gaurav Khatana, Saroj Kanta Sahu, Dibya Lochan Praharaj, Bipadabhanjan Mallick, Preetam Nath, Sridhar Sundaram, Manoj Kumar Sahu
World Journal of Gastrointestinal Endoscopy.2025;[Epub] CrossRef
The Palliation of Unresectable Pancreatic Cancer: Evolution from Surgery to Minimally Invasive Modalities
Muaaz Masood, Shayan Irani, Mehran Fotoohi, Lauren Wancata, Rajesh Krishnamoorthi, Richard A. Kozarek
Journal of Clinical Medicine.2025; 14(14): 4997. CrossRef
The i-EUS consensus on EUS-guided gallbladder drainage: A 3-step modified Delphi approach
Antonio Facciorusso, Cecilia Binda, Stefano Francesco Crinò, Andrea Lisotti, Marco Spadaccini, Arnaldo Amato, Lucio Carrozza, Fausto Catena, Lorenzo Cobianchi, Chiara Coluccio, Edoardo Forti, Lorenzo Fuccio, Dario Ligresti, Marcello Fabio Maida, Aurelio M
Endoscopic Ultrasound.2025; 14(3): 106. CrossRef
The Effect of Lumen-Apposing Metal Stent (LAMS) in Acute Cholecystitis Unfit for Surgery: Good Tidings
Valentina Zadro, Giulia Bertoncini, Giuliano Francesco Bonura, Pablo Cortegoso Valdivia, Noemi Gualandi, Paola Soriani, Tommaso Gabbani, Mauro Manno
Diagnostics.2025; 15(22): 2835. CrossRef
Risk factors and treatment strategies for cholecystitis after metallic stent placement for malignant biliary obstruction: a multicenter retrospective study
Akihiro Matsumi, Hironari Kato, Taiji Ogawa, Toru Ueki, Masaki Wato, Masakuni Fujii, Tatsuya Toyokawa, Ryo Harada, Yuki Ishihara, Masahiro Takatani, Hirofumi Tsugeno, Naoko Yunoki, Takeshi Tomoda, Toshiharu Mitsuhashi, Motoyuki Otsuka
Gastrointestinal Endoscopy.2024; 100(1): 76. CrossRef
The updated Asia-Pacific consensus statement on the role of endoscopic management in malignant hilar biliary obstruction
Phonthep Angsuwatcharakon, Santi Kulpatcharapong, Alan Chuncharunee, Christopher Khor, Benedict Devereaux, Jong Ho Moon, Thawee Ratanachu-ek, Hsiu Po Wang, Nonthalee Pausawasdi, Amit Maydeo, Takao Itoi, Ryan Ponnudurai, Mohan Ramchandani, Yousuke Nakai, D
Endoscopy International Open.2024; 12(09): E1065. CrossRef
Prophylactic endoscopic transpapillary gallbladder stenting to prevent acute cholecystitis induced after metallic stent placement for malignant biliary strictures: a retrospective study in Japan
Fumisato Kozakai, Yoshihide Kanno, Shinsuke Koshita, Takahisa Ogawa, Hiroaki Kusunose, Toshitaka Sakai, Keisuke Yonamine, Kazuaki Miyamoto, Haruka Okano, Yuto Matsuoka, Kento Hosokawa, Hidehito Sumiya, Kei Ito
Clinical Endoscopy.2024; 57(5): 647. CrossRef
Endoscopic Transpapillary Gallbladder Drainage for Recurrent Cholecystitis after Covered Self-expandable Metal Stent Placement for Unresectable Malignant Biliary Obstruction
Akinori Maruta, Takuji Iwashita, Kaori Banno, Takuya Koizumi, Soichi Iritani, Kensaku Yoshida, Shogo Shimizu, Masahito Shimizu
Internal Medicine.2023; 62(2): 237. CrossRef
Treatment Strategy for Acute Cholecystitis Induced by a Metallic Stent Placed in Malignant Biliary Strictures: Role of Percutaneous Transhepatic Gallbladder Aspiration
Fumisato Kozakai, Yoshihide Kanno, Shinsuke Koshita, Takahisa Ogawa, Hiroaki Kusunose, Toshitaka Sakai, Keisuke Yonamine, Kazuaki Miyamoto, Hideyuki Anan, Haruka Okano, Kei Ito
Internal Medicine.2023; 62(5): 673. CrossRef
Prospective feasibility study on the efficacy and safety of a novel spiral dilator for endoscopic ultrasound‐guided drainage
Takahisa Ogawa, Yoshihide Kanno, Shinsuke Koshita, Hiroaki Kusunose, Toshitaka Sakai, Keisuke Yonamine, Kazuaki Miyamoto, Fumisato Kozakai, Haruka Okano, Hideyuki Anan, Kento Hosokawa, Kei Ito
DEN Open.2023;[Epub] CrossRef
Endoscopic ultrasound (EUS)-guided cholecystostomy versus percutaneous cholecystostomy (PTC) in the management of acute cholecystitis in patients unfit for surgery: a systematic review and meta-analysis
Matheus Candido Hemerly, Diogo Turiani Hourneaux de Moura, Epifanio Silvino do Monte Junior, Igor Mendonça Proença, Igor Braga Ribeiro, Erika Yuki Yvamoto, Pedro Henrique Boraschi Vieira Ribas, Sergio A. Sánchez-Luna, Wanderley Marques Bernardo, Eduardo G
Surgical Endoscopy.2023; 37(4): 2421. CrossRef
Trial sequential analysis of EUS-guided gallbladder drainage versus percutaneous cholecystostomy in patients with acute cholecystitis
Alessandro Cucchetti, Cecilia Binda, Elton Dajti, Monica Sbrancia, Giorgio Ercolani, Carlo Fabbri
Gastrointestinal Endoscopy.2022; 95(3): 399. CrossRef
Percutaneous Cholecystostomy: A Bridge to Less Morbidity
Anil Kumar Singh
The Arab Journal of Interventional Radiology.2022; 6(1): 3. CrossRef
Determinants of outcomes of transmural EUS-guided gallbladder drainage: systematic review with proportion meta-analysis and meta-regression
Carlo Fabbri, Cecilia Binda, Monica Sbrancia, Elton Dajti, Chiara Coluccio, Giorgio Ercolani, Andrea Anderloni, Alessandro Cucchetti
Surgical Endoscopy.2022; 36(11): 7974. CrossRef
Endoscopic ultrasound-guided cholecystogastrostomy as an alternative biliary drainage route in malignant obstructions
Marco A. D’Assuncao, Fernando P. Marson, Saverio T. N. Armellini, Fernando L. Mota, Fernando J. S. de Oliveira, Eduardo M. A. Pereira Junior
Endoscopy.2021; 53(07): E277. CrossRef
Efficacy and safety of conversion of percutaneous cholecystostomy to endoscopic transpapillary gallbladder stenting in high-risk surgical patients
Hyung Ku Chon, Chan Park, Dong Eun Park, Tae Hyeon Kim
Hepatobiliary & Pancreatic Diseases International.2021; 20(5): 478. CrossRef
Endoscopic Transpapillary Gallbladder Drainage for Acute Cholecystitis After Biliary Self-Expandable Metal Stent Placement
Kazunari Nakahara, Ryo Morita, Yosuke Michikawa, Keigo Suetani, Nozomi Morita, Akashi Fujita, Junya Sato, Yosuke Igarashi, Hiroki Ikeda, Kotaro Matsunaga, Tsunamasa Watanabe, Shinjiro Kobayashi, Takehito Otsubo, Fumio Itoh
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2020; 30(5): 416. CrossRef
Endoscopic Management of Acute Cholecystitis Following Metal Stent Placement for Malignant Biliary Strictures: A View from the Inside Looking in
Sean Bhalla, Ryan Law
Clinical Endoscopy.2019; 52(3): 209. CrossRef

10,536 View
171 Download
21 Web of Science
21 Crossref

First
Prev
Page of 1
Next
Last

Search